Cargando…

Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology

In oncology, biomarker research aimed to provide insights on cancer biology via positron emission tomography (PET) and single photon emission tomography (SPECT) imaging has seen an incredible growth in the past two decades. Despite the increased number of publications on PET/SPECT radiopharmaceutica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisaneschi, Federica, Viola, Nerissa T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760224/ https://www.ncbi.nlm.nih.gov/pubmed/34542804 http://dx.doi.org/10.1007/s11307-021-01645-6

Ejemplares similares

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

Insight into the Development of PET Radiopharmaceuticals for Oncology
por: Lau, Joseph, et al.
Publicado: (2020)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison
por: Alqahtani, Fawaz F.
Publicado: (2023)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
por: Crișan, George, et al.
Publicado: (2022)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications()
por: Franquet, Elisa, et al.
Publicado: (2022)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review
por: Poletto, Giulia, et al.
Publicado: (2022)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Inclusion of Radiopharmaceuticals in the Indian Pharmacopeia: A Step Forward
por: Meher, Bikash Ranjan
Publicado: (2020)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
por: Rinne, Sara S., et al.
Publicado: (2021)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Radiopharmaceutical Validation for Clinical Use
por: Kunos, Charles A., et al.
Publicado: (2021)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments
por: Haubner, Roland, et al.
Publicado: (2014)

Development of PET and SPECT Probes for Glutamate Receptors
por: Fuchigami, Takeshi, et al.
Publicado: (2015)

PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2021)

A Projection-Domain Low-Count Quantitative SPECT Method for α-Particle-Emitting Radiopharmaceutical Therapy
por: Li, Zekun, et al.
Publicado: (2023)

Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
por: de Vries, E. F. J., et al.
Publicado: (2022)

Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2017)

PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
por: Auletta, Sveva, et al.
Publicado: (2019)

Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
por: Schreuder, Nanno, et al.
Publicado: (2020)

Impact of Nuclear Medicine and Radiopharmaceuticals on Health-care Delivery: Advances, Lessons, and Need for an Objective Value-matrix
por: Ramamoorthy, Natesan
Publicado: (2018)

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
por: Evans, Brendan J., et al.
Publicado: (2020)

Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
por: Declercq, Lieven D., et al.
Publicado: (2016)

SPECT and PET Imaging of Meningiomas
por: Valotassiou, Varvara, et al.
Publicado: (2012)

Development of Folate Receptor−Targeted PET Radiopharmaceuticals for Tumor Imaging—A Bench-to-Bedside Journey
por: Boss, Silvan D., et al.
Publicado: (2020)

EANM guideline on the validation of analytical methods for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2020)

Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals
por: Sardaro, Angela, et al.
Publicado: (2022)

Impact of the dead-time correction method on quantitative (177)Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy
por: Desy, Alessandro, et al.
Publicado: (2022)

Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7lqfc54r3b5j34g05k5n0dgjvs